Retinal Physician

Retinal Physician Therapeutic and Surgical Treatment of the Posterior Segment

🌟 One of 2024's most popular articles! Learn about the latest developments in understanding Stargardt disease and emergi...
12/21/2024

🌟 One of 2024's most popular articles! Learn about the latest developments in understanding Stargardt disease and emerging treatment options here: https://ow.ly/BHuL50UmNF2

The FDA has granted rare pediatric disease destignation to EyeDNA’s investigational gene therapy for retinitis pigmentos...
12/20/2024

The FDA has granted rare pediatric disease destignation to EyeDNA’s investigational gene therapy for retinitis pigmentosa. Read more: https://ow.ly/vCgn50UtwIw

⚙️ Ranked as one of the most popular articles of 2024, this overview dives into the possibilities of retinal prosthesis....
12/20/2024

⚙️ Ranked as one of the most popular articles of 2024, this overview dives into the possibilities of retinal prosthesis. Read more: https://ow.ly/ZgjM50UmNm2

The FDA has approved ViGeneron’s IND for a gene therapy that targets Stargardt disease and ABCA4-linked retinal conditio...
12/19/2024

The FDA has approved ViGeneron’s IND for a gene therapy that targets Stargardt disease and ABCA4-linked retinal conditions. Read more: https://ow.ly/3w0950UtwAc

🔬 This top-read article of 2024 explores the game-changing potential of tyrosine kinase inhibitors for wet AMD and DR. R...
12/19/2024

🔬 This top-read article of 2024 explores the game-changing potential of tyrosine kinase inhibitors for wet AMD and DR. Read more: https://ow.ly/J7Hm50UmNjK

EYLEA HD phase 3 study meets key endpoint as treatment for macular edema secondary to RVO. Read more: https://ow.ly/h4SN...
12/18/2024

EYLEA HD phase 3 study meets key endpoint as treatment for macular edema secondary to RVO. Read more: https://ow.ly/h4SN50Uts7O

Peter K. Kaiser, MD, editor in chief of Retinal Physician for the past 12 years, welcomes Diana V. Do, MD, who takes ov...
12/18/2024

Peter K. Kaiser, MD, editor in chief of Retinal Physician for the past 12 years, welcomes Diana V. Do, MD, who takes over the top editorial position beginning with the January 2025 issue. Read more: https://ow.ly/MWhn50UsWwk

💡 A 2024 reader favorite! Practical strategies for managing dry AMD and optimizing outcomes. https://ow.ly/tgI050UmNi6 ...
12/17/2024

💡 A 2024 reader favorite! Practical strategies for managing dry AMD and optimizing outcomes. https://ow.ly/tgI050UmNi6

View a simultaneous rhegmatogenous retinal detachment and choroidal melanoma in our Ultra-Widefield Image of the Month: ...
12/16/2024

View a simultaneous rhegmatogenous retinal detachment and choroidal melanoma in our Ultra-Widefield Image of the Month: https://ow.ly/fVcN50U6qXk

Avant Technologies and Ainnova Tech have announced plans for an AI-integrated fundus camera. Read more: https://ow.ly/Sp...
12/14/2024

Avant Technologies and Ainnova Tech have announced plans for an AI-integrated fundus camera. Read more: https://ow.ly/Spzo50UmKie

We are excited to welcome Diana V. Do, MD, as the new editor in chief of Retinal Physician, beginning with the January 2...
12/13/2024

We are excited to welcome Diana V. Do, MD, as the new editor in chief of Retinal Physician, beginning with the January 2025 issue! Read more: https://ow.ly/LsOx50UqXHP

📸 Among the top articles of 2024! Insightful imaging for geographic atrophy. Read more: https://ow.ly/1eWB50UmNgm ...
12/13/2024

📸 Among the top articles of 2024! Insightful imaging for geographic atrophy. Read more: https://ow.ly/1eWB50UmNgm

👁️ One of 2024’s most-read articles examined peripheral retinal changes in AMD. Read more: https://ow.ly/jjPW50UmN9C ...
12/10/2024

👁️ One of 2024’s most-read articles examined peripheral retinal changes in AMD. Read more: https://ow.ly/jjPW50UmN9C

Roche and Ainnova have announced a pilot program in Costa Rica that will use AI technology to screen for diabetic retino...
12/07/2024

Roche and Ainnova have announced a pilot program in Costa Rica that will use AI technology to screen for diabetic retinopathy. Read more: https://ow.ly/ScBF50UmK9j

Ocular Therapeutix has completed enrollment in a phase 3 trial for its Axpaxli intravitreal implant. Read more: https://...
12/06/2024

Ocular Therapeutix has completed enrollment in a phase 3 trial for its Axpaxli intravitreal implant. Read more: https://ow.ly/HFWS50UmJTf

Address

321 Norristown Road
Ambler, PA
19382

Website

Alerts

Be the first to know and let us send you an email when Retinal Physician posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Retinal Physician:

Videos

Happy Halloween! Be sure to check out the following tips from the American Academy of Ophthalmology on how to protect your eyes this Halloween: https://ow.ly/50eR50TWI5l. #Halloween

Astellas Pharma x Retinal Physician - Live from AAO 2024!
Astellas Pharma x Retinal Physician - Live from AAO 2024!

Retinal Physician Livestream Alert! Tune in LIVE from the American Academy of Ophthalmology annual meeting as Mona Camacci, MD, and Ankur M. Shah, MD, FASRS, discuss the importance in broad patient selection, beginning treatment early, & the importance of effectively communicating treatment expectations in Geographic Atrophy. Join the conversation right here on our Facebook and YouTube Channel. #Sponsored by Astellas Pharma.

Shortcuts

Share

Category